Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling

Yu, Fa-Xing, Zhao, Bin, Panupinthu, Nattapon, Jewell, Jenna L., Lian, Ian, Wang, Lloyd H., Zhao, Jiagang, Yuan, Haixin +5 more·2012·Cell

Cited by (1,002)

Items 101–200 of 1,002

  1. Understanding the Molecular Genetics of Basal Cell Carcinoma
    Pellegrini, Cristina, Maturo, Maria, Di Nardo, Lucia, Ciciarelli, Valeria, Gutiérrez García-Rodrigo, Carlota, Fargnoli, Maria · 2017 · International Journal of Molecular Sciences
  2. An FAK-YAP-mTOR Signaling Axis Regulates Stem Cell-Based Tissue Renewal in Mice
    Jimmy Kuang‐Hsien Hu, Wei Ting Du, Samuel J. Shelton, Michael C. Oldham, C. Michael DiPersio, Ophir D. Klein · 2017 · Cell stem cell
  3. WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis
    Hong Ouyang, Yuanchao Xue, Ying Lin, Xiaohui Zhang, Lei Xi, Sherrina H. Patel, Huimin Cai, Jing Luo, Meixia Zhang, Ming Zhang et al. · 2014 · Nature
  4. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis
    Knipe, Rachel S., Tager, Andrew M., Liao, James K. · 2015 · Pharmacological Reviews
  5. Hippo Signaling in Embryogenesis and Development
    ZhengMing Wu, Kun‐Liang Guan · 2020 · Trends in Biochemical Sciences
  6. The Hippo Pathway in Liver Homeostasis and Pathophysiology
    Jordan H. Driskill, Duojia Pan · 2020 · Annual Review of Pathology Mechanisms of Disease
  7. Disease implications of the Hippo/YAP pathway
    Steven W. Plouffe, Audrey W. Hong, Kun‐Liang Guan · 2015 · Trends in Molecular Medicine
  8. Estrogen regulates Hippo signaling via GPER in breast cancer
    Zhou, Xin, Wang, Shuyang, Wang, Zhen, Feng, Xu, Liu, Peng, Lv, Xian-Bo, Li, Fulong, Yu, Fa-Xing, Sun, Yiping, Yuan, Haixin et al. · 2015 · Journal of Clinical Investigation
  9. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase
    Isabel Serrano, Paul C. McDonald, Frances E. Lock, William J. Muller, Shoukat Dedhar · 2013 · Nature Communications
  10. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
    Ajaybabu V. Pobbati, Wanjin Hong · 2020 · Theranostics
  11. Intestinal Regeneration: Regulation by the Microenvironment
    Joris H. Hageman, Maria C. Heinz, Kai Kretzschmar, Jelte van der Vaart, Hans C. Clevers, Hugo J.G. Snippert · 2020 · Developmental Cell
  12. Insights into recent findings and clinical application of YAP and TAZ in cancer
    Franklin, J. Matthew, Wu, Zhengming, Guan, Kun-Liang · 2023 · Nature Reviews Cancer
  13. The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development
    Barry, Evan R, Camargo, Fernando D · 2013 · Current Opinion in Cell Biology
  14. Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Sayan Chakraborty, Kizito Njah, Ajaybabu V. Pobbati, Ying Bena Lim, Anandhkumar Raju, Manikandan Lakshmanan, Vinay Tergaonkar, Chwee Teck Lim, Wanjin Hong · 2017 · Cell Reports
  15. Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade
    Yonggang Zheng, Wei Wang, Bo Liu, Hua Deng, Eliza Uster, Duojia Pan · 2015 · Developmental Cell
  16. The Hippo Pathway in Heart Development, Regeneration, and Diseases
    Qi Zhou, Li Li, Bin Zhao, Kun‐Liang Guan · 2015 · Circulation Research
  17. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis
    Andrew J. Haak, Enis Kostallari, Delphine Sicard, Giovanni Ligresti, Kyoung Moo Choi, Nunzia Caporarello, Dakota L. Jones, Qi Tan, Jeffrey A. Meridew, Ana Maria Diaz Espinosa et al. · 2019 · Science Translational Medicine
  18. cAMP/PKA signalling reinforces the LATS–YAP pathway to fully suppress YAP in response to actin cytoskeletal changes
    Minchul Kim, Mi‐Ju Kim, Seung‐Hee Lee, Shinji Kuninaka, Hideyuki Saya, Ho Lee, Sookyung Lee, Dae‐Sik Lim · 2013 · The EMBO Journal
  19. An Insight into GPCR and G-Proteins as Cancer Drivers
    Preeti Kumari Chaudhary, Soochong Kim · 2021 · Cells
  20. Mutual dependence of the MRTF–SRF and YAP–TEAD pathways in cancer-associated fibroblasts is indirect and mediated by cytoskeletal dynamics
    Foster, Charles T., Gualdrini, Francesco, Treisman, Richard · 2017 · Genes & Development
  21. YAP/TAZ as therapeutic targets in cancer
    Francesca Zanconato, Giusy Battilana, Michelangelo Cordenonsi, Stefano Piccolo · 2016 · Current Opinion in Pharmacology
  22. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
    Andrew Graham Cox, Katie L. Hwang, Kristin Brown, Kimberley Jane Evason, Sebastian Beltz, Allison Tsomides, Keelin O’Connor, Giorgio Giacomo Galli, Dean Yimlamai, Sagar Chhangawala et al. · 2016 · Nature Cell Biology
  23. MicroRNA-31 Reduces Inflammatory Signaling and Promotes Regeneration in Colon Epithelium, and Delivery of Mimics in Microspheres Reduces Colitis in Mice
    Yuhua Tian, Jiuzhi Xu, Yuan Li, Ran Zhao, Sujuan Du, Cong Lv, Wei Hua Wu, Ruiqi Liu, Xiaole Sheng, Yongli Song et al. · 2019 · Gastroenterology
  24. Function and cancer genomics of FAT family genes
    Masaru Katoh · 2012 · International Journal of Oncology
  25. G Protein-Coupled Receptors in Cancer
    Rachel Bar‐Shavit, Myriam Maoz, Arun Kancharla, Jeetendra Kumar Nag, Daniel Agranovich, Sorina Grisaru‐Granovsky, Beatrice Uziely · 2016 · International Journal of Molecular Sciences
  26. The role of YAP/TAZ activity in cancer metabolic reprogramming
    Xiaodong Zhang, Haiying Zhao, Yan Li, Di Xia, Liang Yang, Yingbo Ma, Hangyu Li · 2018 · Molecular Cancer
  27. Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
    Liang, Ning, Zhang, Chi, Dill, Patricia, Panasyuk, Ganna, Pion, Delphine, Koka, Vonda, Gallazzini, Morgan, Olson, Eric N., Lam, Hilaire, Henske, Elizabeth P. et al. · 2014 · Journal of Experimental Medicine
  28. Expression of α-Smooth Muscle Actin Determines the Fate of Mesenchymal Stromal Cells
    Nilesh P. Talele, Julie Fradette, John Edward Davies, András Kapùs, Boris Hinz · 2015 · Stem Cell Reports
  29. Tankyrase Inhibitors Target YAP by Stabilizing Angiomotin Family Proteins
    Wenqi Wang, Nan Li, Xu Li, My Kim Tran, Xin Han, Junjie Chen · 2015 · Cell Reports
  30. Angiomotins link F-actin architecture to Hippo pathway signaling
    Sebastian Mana‐Capelli, Murugan Paramasivam, Shubham Dutta, Dannel McCollum · 2014 · Molecular Biology of the Cell
  31. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade
    Qian Zhang, Fansen Meng, Shasha Chen, Steven W. Plouffe, Shiying Wu, Shengduo Liu, Xinran Li, Ruyuan Zhou, Junxian Wang, Bin Zhao et al. · 2017 · Nature Cell Biology
  32. Hippo signalling in the liver: role in development, regeneration and disease
    Jacquelyn Olivia Russell, Fernando D. Camargo · 2022 · Nature Reviews Gastroenterology & Hepatology
  33. Biophysical Regulation of Chromatin Architecture Instills a Mechanical Memory in Mesenchymal Stem Cells
    Su‐Jin Heo, Stephen D. Thorpe, Tristan P. Driscoll, Randall L. Duncan, David A. Lee, Robert L. Mauck · 2015 · Scientific Reports
  34. The Hippo signaling pathway in development and regeneration
    Zhenxing Zhong, Zhihan Jiao, Fa‐Xing Yu · 2024 · Cell Reports
  35. Actin remodelling factors control ciliogenesis by regulating YAP/TAZ activity and vesicle trafficking
    Jongshin Kim, Haiin Jo, Hyowon Hong, Jin Man Kim, Jin Man Kim, June-Koo Lee, Won Do Heo, Joon Kim · 2015 · Nature Communications
  36. Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
    Kimberly C. Lin, Toshiro Moroishi, Zhipeng Meng, Han-Sol Jeong, Steven W. Plouffe, Yoshitaka Sekido, Jiahuai Han, Hyun Woo Park, Kun‐Liang Guan · 2017 · Nature Cell Biology
  37. Exercise training in cancer control and treatment
    Christensen, Jesper Frank, Simonsen, Casper, Hojman, Pernille · 2018 · Comprehensive physiology
  38. Mechanotransduction and fibrosis
    Dominik Duscher, Zeshaan N. Maan, VW Wong, Robert Charles Rennert, Michael Januszyk, Mélanie Rodrigues, Michael Sung-Min Hu, Arnetha J. Whitmore, Alexander J. Whittam, Michael Thornton Longaker et al. · 2014 · Journal of Biomechanics
  39. Small-Molecule Covalent Modification of Conserved Cysteine Leads to Allosteric Inhibition of the TEAD⋅Yap Protein-Protein Interaction
    Khuchtumur Bum‐Erdene, Donghui Zhou, Giovanni González-Gutiérrez, Mona K. Ghozayel, Yubing Si, David Daqiang Xu, Harlan E. Shannon, Barbara J. Bailey, Timothy W. Corson, Karen E. Pollok et al. · 2018 · Cell chemical biology
  40. YAP Induces Human Naive Pluripotency
    Han Qin, Miroslav Hejna, Yanxia Liu, Michelle Percharde, Mark Wossidlo, Laure Blouin, Jens Durruthy-Durruthy, Priscilla Wong, Zhongxia Qi, Jingwei Yu et al. · 2016 · Cell Reports
  41. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKɛ-mediated phosphorylation
    Shuai Wang, Feng Xie, Feng Chu, Zhengkui Zhang, Bing Yang, Tong Dai, Liang Gao, Lin Wang, Li Ling, Junling Jia et al. · 2017 · Nature Immunology
  42. The Role of Hippo Pathway in Cancer Stem Cell Biology.
    Jae Hyung Park, Ji Eun Shin, Hyun Woo Park · 2018 · PubMed Central
  43. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism
    Patra, Krushna C., Kato, Yasutaka, Mizukami, Yusuke, Widholz, Sebastian, Boukhali, Myriam, Revenco, Iulia, Grossman, Elizabeth A., Ji, Fei, Sadreyev, Ruslan I., Liss, Andrew S. et al. · 2018 · Nature Cell Biology
  44. The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells
    Judson, Robert N., Tremblay, Annie M., Knopp, Paul, White, Robert B., Urcia, Roby, De Bari, Cosimo, Zammit, Peter S., Camargo, Fernando D., Wackerhage, Henning · 2012 · Journal of Cell Science
  45. Integration of Hippo-YAP Signaling with Metabolism
    Consuelo Ibar, Kenneth D. Irvine · 2020 · Developmental Cell
  46. Exercise-Induced Catecholamines Activate the Hippo Tumor Suppressor Pathway to Reduce Risks of Breast Cancer Development
    Christine Dethlefsen, Louise Seier Hansen, Christian Lillelund, Christina Andersen, Julie Gehl, Jesper Frank Christensen, Bente Klarlund Pedersen, Pernille Højman · 2017 · Cancer Research
  47. Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury
    Jun-Jae Chung, Leonard D. Goldstein, Ying-Jiun J. Chen, Jiyeon Lee, Joshua D. Webster, Merone Roose‐Girma, Sharad C. Paudyal, Zora D. Modrusan, Anwesha Dey, Andréy S. Shaw · 2020 · Journal of the American Society of Nephrology
  48. Implant Fibrosis and the Underappreciated Role of Myofibroblasts in the Foreign Body Reaction
    Noskovicova, Nina, Hinz, Boris, Pakshir, Pardis · 2021 · Cells
  49. SET1A-Mediated Mono-Methylation at K342 Regulates YAP Activation by Blocking Its Nuclear Export and Promotes Tumorigenesis
    Lan Fang, Hongqi Teng, Yilin Wang, Guanghong Liao, Linjun Weng, Yaxu Li, Xinbo Wang, Jiali Jin, Chenchen Jiao, Lei Chen et al. · 2018 · Cancer Cell
  50. Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction
    Vimal Ramjee, Deqiang Li, Lauren J. Manderfield, Feiyan Liu, Kurt A. Engleka, Haig K. Aghajanian, Christopher B. Rodell, Wen Ying Lu, Vivienne C. Ho, Tao Wang et al. · 2017 · Journal of Clinical Investigation
  51. Matrix mechanotransduction mediated by thrombospondin-1/integrin/YAP in the vascular remodeling
    Yoshito Yamashiro, Bui Quoc Thang, Karina Ramirez, Seung Jae Shin, Tomohiro Kohata, Shigeaki Ohata, Tram Anh Vu Nguyen, Sumio Ohtsuki, Kazuaki NAGAYAMA, Hiromi Yanagisawa · 2020 · Proceedings of the National Academy of Sciences
  52. A basal-like breast cancer-specific role for SRF–IL6 in YAP-induced cancer stemness
    Tackhoon Kim, Suk-Jin Yang, Daehee Hwang, Jinhoi Song, Minchul Kim, Sang Kyum Kim, Keunsoo Kang, Jaebum Ahn, Daeyoup Lee, Mi‐Young Kim et al. · 2015 · Nature Communications
  53. DNA binding partners of YAP/TAZ
    Min‐Kyu Kim, Juwon Jang, Suk‐Chul Bae · 2018 · BMB Reports
  54. Illuminating the Onco-GPCRome: Novel G protein–coupled receptor-driven oncocrine networks and targets for cancer immunotherapy
    Victoria H. Wu, Huwate Yeerna, Nijiro Nohata, Joshua Chiou, Olivier Harismendy, Francesco Raimondi, Asuka Inoue, Robert B. Russell, Pablo Tamayo, Jorge Silvio Gutkind · 2019 · Journal of Biological Chemistry
  55. Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers
    Yusuke Oku, Naoyuki Nishiya, Toshiya Shito, Reiichiro Yamamoto, Yasufumi Yamamoto, Chihiro Oyama, Yoshimasa Uehara · 2015 · FEBS Open Bio
  56. Melatonin and Hippo Pathway: Is There Existing Cross-Talk?
    Federica Lo Sardo, Paola C. Muti, Giovanni Blandino, Sabrina Strano · 2017 · International Journal of Molecular Sciences
  57. Glucocorticoid receptor signalling activates YAP in breast cancer
    Giovanni Sorrentino, Naomi Ruggeri, Alessandro Zannini, Eleonora Ingallina, Rebecca Bertolio, Carolina Marotta, Carmelo Neri, Elisa Cappuzzello, Mattia Forcato, Antonio Rosato et al. · 2017 · Nature Communications
  58. Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer
    Dean Yimlamai, Brendan H. Fowl, Fernando D. Camargo · 2015 · Journal of Hepatology
  59. GPCRs: Emerging anti-cancer drug targets
    Ainhoa Nieto, Patricia H. McDonald · 2017 · Cellular Signalling
  60. Making a good egg: human oocyte health, aging, and in vitro development
    Evelyn E. Telfer, Johanne Grosbois, Yvonne L. Odey, Roseanne Rosario, Richard A. Anderson · 2023 · Physiological Reviews
  61. Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2
    Shi-Hao Zhang, Qing-Hua Chen, Qingxu Liu, Yuxi Li, Xiu-Feng Sun, Li-Xin Hong, Suyuan Ji, Cheng-Yan Liu, Jing Geng, Weiji Zhang et al. · 2017 · Cancer Cell
  62. The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis
    Chunling Yi, Zhewei Shen, Anat O Stemmer-Rachamimov, Noor B. Dawany, Scott A. Troutman, Louise C. Showe, Qin Liu, Akihiko Shimono, Marius Sudol, Lars Holmgren et al. · 2013 · Science Signaling
  63. Neuregulin 1–activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration
    Jonathan W. Haskins, Don X. Nguyen, David F. Stern · 2014 · Science Signaling
  64. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways
    Giulia Santinon, Arianna Pocaterra, Sirio Dupont · 2015 · Trends in Cell Biology
  65. The Hippo Pathway and YAP/TAZ–TEAD Protein–Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
    Matteo Santucci, Tatiana Vignudelli, Stefania Ferrari, Marco Mor, Laura Scalvini, María Laura Bolognesi, Elisa Uliassi, Maria Paola Costi · 2015 · Journal of Medicinal Chemistry
  66. The Hippo pathway in normal development and cancer
    Marcello Maugeri‐Saccà, Ruggero D. Maria · 2018 · Pharmacology & Therapeutics
  67. YAP/TAZ Activation as a Target for Treating Metastatic Cancer
    Janine Warren, Yuxuan Xiao, John M. Lamar · 2018 · Cancers
  68. Yap/Taz deletion in Gli(+) cell-derived myofibroblasts attenuates fibrosis
    Liang, Ming, Yu, Michael, Xia, Ruohan, Song, Ke, Wang, Jun, Luo, Jinlong, Chen, Guang, Cheng, Jizhong · 2017 · Journal of the American Society of Nephrology
  69. The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size
    Watt, K. I., Turner, B. J., Hagg, A., Zhang, X., Davey, J. R., Qian, H., Beyer, C., Winbanks, C. E., Harvey, K. F., Gregorevic, P. · 2015 · Nature Communications
  70. Integration of Hippo signalling and the unfolded protein response to restrain liver overgrowth and tumorigenesis
    Hongtan Wu, Luyao Wei, Fuqin Fan, Suyuan Ji, Shihao Zhang, Jing Geng, Lixin Hong, Xin Fan, Qinghua Chen, Jing Tian et al. · 2015 · Nature Communications
  71. Control of stem cell renewal and fate by YAP and TAZ
    Jordan H. Driskill, Duojia Pan · 2023 · Nature Reviews Molecular Cell Biology
  72. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells
    Namrata Bora-Singhal, Jonathan V. Nguyen, Courtney M. Schaal, Deepak Perumal, Sandeep Singh, Domenico Coppola, Srikumar Chellappan · 2015 · Stem Cells
  73. MST kinases in development and disease
    Barry J. Thompson, Erik A. Sahai · 2015 · The Journal of Cell Biology
  74. The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
    Hui Cai, Yan Xu · 2013 · Cell Communication and Signaling
  75. Hippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism
    Amin Dakhili Ardestani, Blaž Lupše, Kathrin Maedler · 2018 · Trends in Endocrinology and Metabolism
  76. A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
    Taha Azad, Helena J. Janse van Rensburg, Elizabeth D. Lightbody, Bertrand Neveu, Audrey Champagne, Abdi Ghaffari, Vanessa R. Kay, Yutong Hao, He Shen, Benjamin Yeung et al. · 2018 · Nature Communications
  77. Regulation of Hippo signaling by actin remodeling
    Jimyung Seo, Joon Kim · 2018 · BMB Reports
  78. Sensing the local environment: actin architecture and Hippo signalling
    Pedro Gaspar, Nicolas Tapon · 2014 · Current Opinion in Cell Biology
  79. Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway
    Ursula Ehmer, Julien Sage · 2015 · Molecular Cancer Research
  80. Osmotic stress‐induced phosphorylation by NLK at Ser128 activates YAP
    Audrey W. Hong, Zhipeng Meng, Hai‐Xin Yuan, Steven W. Plouffe, Sungho Moon, Wantae Kim, Eek‐hoon Jho, Kun‐Liang Guan · 2016 · EMBO Reports
  81. WW Domain-Containing Proteins YAP and TAZ in the Hippo Pathway as Key Regulators in Stemness Maintenance, Tissue Homeostasis, and Tumorigenesis
    Yu-An Chen, Chen-Yu Lu, Tian‐You Cheng, Szu‐Hua Pan, Hsin‐Fu Chen, Nan‐Shan Chang · 2019 · Frontiers in Oncology
  82. YAP promotes the activation of NLRP3 inflammasome via blocking K27-linked polyubiquitination of NLRP3
    Dan Wang, Yening Zhang, Xueming Xu, Jianfeng Wu, Yue Peng, Jing Li, Ruiheng Luo, Lingmin Huang, Liping Liu, Songlin Yu et al. · 2021 · Nature Communications
  83. Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis
    Xiaoming Dai, Peilu She, Fangtao Chi, Ying Feng, Huan Liu, Daqing Jin, Yiqiang Zhao, Xiaocan Guo, Dandan Jiang, Kun‐Liang Guan et al. · 2013 · Journal of Biological Chemistry
  84. Molecular Pathways: YAP and TAZ Take Center Stage in Organ Growth and Tumorigenesis
    Stefano Piccolo, Michelangelo Cordenonsi, Sirio Dupont · 2013 · Clinical Cancer Research
  85. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival
    Yanfei Yang, Dominic P. Del Re, Noritsugu Nakano, Sebastiano Sciarretta, Peiyong Zhai, Jiyeon Park, Danish H Sayed, Akihiro Shirakabe, Shoji Matsushima, Yongkyu Park et al. · 2015 · Circulation Research
  86. LPA 1 ‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation
    Norihiko Sakai, Jerold J. M. Chun, Jeremy S. Duffield, Takashi Wada, Andrew David Luster, Andrew Martin Tager · 2013 · The FASEB Journal
  87. YAP1 and its fusion proteins in cancer initiation, progression and therapeutic resistance
    Frank Szulzewsky, Eric C. Holland, Valeri I. Vasioukhin · 2021 · Developmental Biology
  88. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases
    Jacob J. Adler, Derrick E. Johnson, Brigitte L. Heller, Lauren R. Bringman, William P. Ranahan, Michael D. Conwell, Yang Sun, Andy Hudmon, Clark D. Wells · 2013 · Proceedings of the National Academy of Sciences
  89. Inactivation of a Gαs–PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis
    Ramiro Iglesias‐Bartolomé, Daniela Torres, Romina Marone, Xiaodong Feng, Daniel Martı́n, May Simaan, Min Chen, Lee Scott Weinstein, Susan Serota Taylor, Alfredo Molinolo et al. · 2015 · Nature Cell Biology
  90. Mechanoregulation and pathology of YAP/TAZ via Hippo and non‐Hippo mechanisms
    Oleg Dobrokhotov, Mikhail Samsonov, Masahiro Sokabe, Hiroaki Hirata · 2018 · Clinical and Translational Medicine
  91. Cancer signaling, cell/gene therapy, diagnosis and role of nanobiomaterials
    Gvozden Luka Rosic · 2024 · Advances in Biology & Earth Sciences
  92. Signals and Receptors
    Carl‐Henrik Heldin, Benson C. Lu, Ronald M. Evans, Jorge Silvio Gutkind · 2016 · Cold Spring Harbor Perspectives in Biology
  93. Nanoparticle-Based Hybrid Scaffolds for Deciphering the Role of Multimodal Cues in Cardiac Tissue Engineering
    Junmin Lee, Vijayan Manoharan, Louis Cheung, Seungkyu Lee, Byung-Hyun Cha, Peter L. H. Newman, Razieh Farzad, Shreya Mehrotra, Kaizhen Zhang, Fazal Khan et al. · 2019 · ACS Nano
  94. Endothelial mechanobiology in atherosclerosis
    Xiaoli Wang, Yang Shen, Min Shang, Xiaoheng Liu, Lance L. Munn · 2023 · Cardiovascular Research
  95. Therapeutic targeting of TEAD transcription factors in cancer
    Pobbati, Ajaybabu V., Kumar, Ramesh, Rubin, Brian P., Hong, Wanjin · 2023 · Trends in Biochemical Sciences
  96. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer
    Shenghong Ma, Tracy Tzu-Ling Tang, Gary D. Probst, Andrei William Konradi, Chunyu Jin, Fulong Li, Jorge Silvio Gutkind, Xiang‐Dong Fu, Kun‐Liang Guan · 2022 · Nature Communications
  97. The Hippo pathway in tissue homeostasis and regeneration
    Yu Wang, Aijuan Yu, Fa‐Xing Yu · 2017 · Protein & Cell
  98. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer
    Courtney M. Schaal, Namrata Bora-Singhal, Durairaj Mohan Kumar, Srikumar Chellappan · 2018 · Molecular Cancer
  99. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1
    Yuan Si, Xinyan Ji, Xiaolei Cao, Xiaoming Dai, Lingyi Xu, Hongxia Zhao, Xiaocan Guo, Huan Yan, Haitao Zhang, Chu Zhu et al. · 2017 · Cancer Research
  100. The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
    Shuai Wang, Lili Zhou, Li Ling, Xuli Meng, Feng Chu, Suping Zhang, Fangfang Zhou · 2020 · Frontiers in Immunology